J.W. Cole Advisors Inc. Buys 3,115 Shares of Davis Select U.S. Equity ETF (NASDAQ:DUSA)

J.W. Cole Advisors Inc. grew its stake in Davis Select U.S. Equity ETF (NASDAQ:DUSAGet Rating) by 26.5% in the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 14,859 shares of the healthcare company’s stock after purchasing an additional 3,115 shares during the period. J.W. Cole Advisors Inc.’s holdings in Davis Select U.S. Equity ETF were worth $490,000 at the end of the most recent reporting period.

Several other institutional investors have also modified their holdings of the stock. Jane Street Group LLC bought a new stake in shares of Davis Select U.S. Equity ETF during the 1st quarter worth approximately $2,382,000. Next Level Private LLC lifted its stake in shares of Davis Select U.S. Equity ETF by 130.5% during the 1st quarter. Next Level Private LLC now owns 49,185 shares of the healthcare company’s stock worth $1,622,000 after acquiring an additional 27,843 shares during the last quarter. Commonwealth Equity Services LLC lifted its stake in shares of Davis Select U.S. Equity ETF by 31.2% during the 1st quarter. Commonwealth Equity Services LLC now owns 106,715 shares of the healthcare company’s stock worth $3,519,000 after acquiring an additional 25,353 shares during the last quarter. UBS Group AG lifted its stake in shares of Davis Select U.S. Equity ETF by 5.9% during the 1st quarter. UBS Group AG now owns 430,448 shares of the healthcare company’s stock worth $14,196,000 after acquiring an additional 23,825 shares during the last quarter. Finally, LPL Financial LLC lifted its stake in shares of Davis Select U.S. Equity ETF by 8.4% during the 4th quarter. LPL Financial LLC now owns 247,854 shares of the healthcare company’s stock worth $8,474,000 after acquiring an additional 19,241 shares during the last quarter.

Davis Select U.S. Equity ETF Price Performance

Shares of DUSA stock opened at $27.46 on Tuesday. Davis Select U.S. Equity ETF has a 52-week low of $26.64 and a 52-week high of $36.42. The stock has a 50 day moving average price of $28.47 and a 200 day moving average price of $29.63.

Davis Select U.S. Equity ETF Company Profile

(Get Rating)

DUSA Pharmaceuticals, Inc (DUSA) is a vertically integrated dermatology company. The Company is developing and marketing Levulan photodynamic therapy (Levulan PDT). The Company’s marketed products include Levulan Kerastick 20% topical solution with PDT and the BLU-U brand light source. Levulan Kerastick and BLU-U are used for the treatment of non-hyperkeratotic actinic keratoses (AKs), of the face or scalp.

Read More

Want to see what other hedge funds are holding DUSA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Davis Select U.S. Equity ETF (NASDAQ:DUSAGet Rating).

Institutional Ownership by Quarter for Davis Select U.S. Equity ETF (NASDAQ:DUSA)

Receive News & Ratings for Davis Select U.S. Equity ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Davis Select U.S. Equity ETF and related companies with MarketBeat.com's FREE daily email newsletter.